Frontlight ResearchEarly access
CompletedNo phase
NightWare Randomized Trial 02
Key facts
- Who runs it
- NightWare
- Where
- Bethesda, Charleston, Cleveland, and Minneapolis, United StatesSee the 4 sites
- Trial code
- Status
- Completed
- People taking part
- 270 people enrolled
- Started
- 24 Jul 2019
- Ended
- 2 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- NightWare Therapeutic System
- Sham NightWare
- Record updated
- 14 April 2026
Who can take part
- Age
- 22 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 28 criteriaShow less
Who can take part
- Veterans and Active-Duty Service Member Enrolled in the Minneapolis/St. Cloud VAHCS, Louis Stokes VAHCS in Cleveland, Walter Reed National Military Medical Center, or Fort Belvoir Community Hospital
- Diagnosis of PTSD via American Psychiatric Association PTSD diagnostic criteria in the fifth edition of its Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
- Equal to or older than 22 years of age
- Proficient in both reading and writing in the English language
- Pittsburgh Sleep Quality Index (PSQI) score 10 or higher
- Epworth Sleepiness Scale (ESS): On question #8 any score above "0" will prompt an additional question: Do you drive ("get behind the wheel") when you are drowsy? The answer must be "No" to be enrolled in the study due to safety concerns
- Have repetitive nightmares contributing to disrupted sleep as reported by the patient
- Wireless Internet and two power outlets where they sleep
- Prazosin use; if yes, the patient may be included if tapered by prescribing provider. Taper must be completed and subject must be off prazosin for 2 days prior to enrollment
Who cannot take part
- Drug Abuse Screening Test-10 (DAST-10) (score greater than 2)
- Previous or foreseeable legal proceedings involving nightmares or trauma
- Acting out of dreams prior to PTSD trauma
- Diagnosis of an active disorder of arousal from non-rapid eye movement sleep
- Diagnosis of rapid eye movement sleep behavior disorder
- Alcohol Use Disorders Inventory Test (AUDIT) (score of 8 or higher)
- Diagnosis or suspicion of dementia
- Patient Health Questionnaire-9 (PHQ-9) score greater than or equal to 20. A score of 1 or more on the suicide ideation item of the PHQ-9 will trigger a risk assessment
- Uncontrolled atrial fibrillation
- Current use of varenicline
- Current use of beta-blockers (unless ophthalmic solutions)
- Current use of non-dihydropyridines
- Current use of Prazosin for the treatment of nightmares (can include patients 2 days following taper and discontinuation) This would be coordinated with the prescribing provider
- Circadian rhythm disruption on a regular basis (shift-work)
- Untreated Obstructive Sleep Apnea
- Diagnosis of narcolepsy
- Suspicion of nightmares being secondary to substance abuse or withdrawal
- Nocturia that causes awakening from sleep
- Known sleepwalking
Where in United States
- Walter Reed National Military Medical CenterBethesda, United States
- Ralph H. Johnson Veterans Affairs Medical CenterCharleston, United States
- Louis Stokes Cleveland VA Medical CenterCleveland, United States
- Minneapolis VA Healthcare SystemMinneapolis, United States
About the trial
What the trial wants to find out
This study will provide preliminary estimates of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated with post-traumatic stress disorder (PTSD)-related sleep disturbance and the impact of improved sleep with the NightWare digital therapeutic system. The investigators hypothesize that the NightWare digital therapeutic system will significantly improve sleep quality in participants with PTSD-Related nightmares and poor sleep quality.
The 2 groups in the trial
- Treatment ArmTreatment being tested
Intervention with NightWare Therapeutic System
Treatment: NightWare Therapeutic System
- Sham ArmSham treatment, for comparison
NightWare system set to not provide any interventions
Treatment: Sham NightWare
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- TNT/NW: Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)
- Publications
- A randomized sham-controlled clinical trial of a novel wearable intervention for trauma-related nightmares in military veterans.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023
- Record updated
- 14 April 2026